Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy

Cathy Mast, Ramesk K Ramanathan, Donald I. Feinstein, Peter Rosen

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Both solid and hematologic malignancies may be complicated by coagulopathies. Disseminated intravascular coagulation (DIC) in the presence of pancreatic cancer is generally unrecognized and may have fatal consequences. The diagnosis of DIC in a patient with advanced cancer is a poor prognostic indicator. Presented here is a case study consisting of two patients presenting with a new diagnosis of pancreatic cancer complicated by DIC. Aggressive supportive treatment in addition to systemic chemotherapy consisting of gemcitabine and nabpaclitaxel was initiated and DIC was controlled. An early diagnosis of DIC and the administration of systemic chemotherapy with a high response rate and an ability to reduce tumor bulk rapidly may offer some patients the probability of recovery.

Original languageEnglish (US)
Pages (from-to)266-269
Number of pages4
JournalOncology (Switzerland)
Volume87
Issue number5
DOIs
StatePublished - Nov 19 2014
Externally publishedYes

Fingerprint

Disseminated Intravascular Coagulation
Combination Drug Therapy
Pancreatic Neoplasms
gemcitabine
Drug Therapy
Hematologic Neoplasms
Early Diagnosis
Neoplasms

Keywords

  • Advanced pancreatic cancer
  • Combination chemotherapy
  • Disseminated intravascular coagulation

ASJC Scopus subject areas

  • Medicine(all)
  • Oncology
  • Cancer Research

Cite this

Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy. / Mast, Cathy; Ramanathan, Ramesk K; Feinstein, Donald I.; Rosen, Peter.

In: Oncology (Switzerland), Vol. 87, No. 5, 19.11.2014, p. 266-269.

Research output: Contribution to journalArticle

@article{5402e61c6117413586b22354052074da,
title = "Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy",
abstract = "Both solid and hematologic malignancies may be complicated by coagulopathies. Disseminated intravascular coagulation (DIC) in the presence of pancreatic cancer is generally unrecognized and may have fatal consequences. The diagnosis of DIC in a patient with advanced cancer is a poor prognostic indicator. Presented here is a case study consisting of two patients presenting with a new diagnosis of pancreatic cancer complicated by DIC. Aggressive supportive treatment in addition to systemic chemotherapy consisting of gemcitabine and nabpaclitaxel was initiated and DIC was controlled. An early diagnosis of DIC and the administration of systemic chemotherapy with a high response rate and an ability to reduce tumor bulk rapidly may offer some patients the probability of recovery.",
keywords = "Advanced pancreatic cancer, Combination chemotherapy, Disseminated intravascular coagulation",
author = "Cathy Mast and Ramanathan, {Ramesk K} and Feinstein, {Donald I.} and Peter Rosen",
year = "2014",
month = "11",
day = "19",
doi = "10.1159/000365552",
language = "English (US)",
volume = "87",
pages = "266--269",
journal = "Oncology",
issn = "0030-2414",
publisher = "UBM Medica Healthcare Publications",
number = "5",

}

TY - JOUR

T1 - Disseminated intravascular coagulation secondary to advanced pancreatic cancer treated successfully with combination chemotherapy

AU - Mast, Cathy

AU - Ramanathan, Ramesk K

AU - Feinstein, Donald I.

AU - Rosen, Peter

PY - 2014/11/19

Y1 - 2014/11/19

N2 - Both solid and hematologic malignancies may be complicated by coagulopathies. Disseminated intravascular coagulation (DIC) in the presence of pancreatic cancer is generally unrecognized and may have fatal consequences. The diagnosis of DIC in a patient with advanced cancer is a poor prognostic indicator. Presented here is a case study consisting of two patients presenting with a new diagnosis of pancreatic cancer complicated by DIC. Aggressive supportive treatment in addition to systemic chemotherapy consisting of gemcitabine and nabpaclitaxel was initiated and DIC was controlled. An early diagnosis of DIC and the administration of systemic chemotherapy with a high response rate and an ability to reduce tumor bulk rapidly may offer some patients the probability of recovery.

AB - Both solid and hematologic malignancies may be complicated by coagulopathies. Disseminated intravascular coagulation (DIC) in the presence of pancreatic cancer is generally unrecognized and may have fatal consequences. The diagnosis of DIC in a patient with advanced cancer is a poor prognostic indicator. Presented here is a case study consisting of two patients presenting with a new diagnosis of pancreatic cancer complicated by DIC. Aggressive supportive treatment in addition to systemic chemotherapy consisting of gemcitabine and nabpaclitaxel was initiated and DIC was controlled. An early diagnosis of DIC and the administration of systemic chemotherapy with a high response rate and an ability to reduce tumor bulk rapidly may offer some patients the probability of recovery.

KW - Advanced pancreatic cancer

KW - Combination chemotherapy

KW - Disseminated intravascular coagulation

UR - http://www.scopus.com/inward/record.url?scp=84906020006&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906020006&partnerID=8YFLogxK

U2 - 10.1159/000365552

DO - 10.1159/000365552

M3 - Article

C2 - 25139314

AN - SCOPUS:84906020006

VL - 87

SP - 266

EP - 269

JO - Oncology

JF - Oncology

SN - 0030-2414

IS - 5

ER -